Your browser doesn't support javascript.
loading
Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients.
Ghaznavi, Habib; Mohammadghasemipour, Zahra; Shirvaliloo, Milad; Momeni, Mohammad Kazem; Metanat, Malihe; Gorgani, Farzaneh; Abedipour, Fatemeh; Mohammadi, Mahdi; Sartipi, Majid; Khorashad, Ali Reza Salimi; Shahraki, Omolbanin; Ataee, Mohadese; Sheervalilou, Roghayeh; Sargazi, Saman.
Afiliação
  • Ghaznavi H; Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Mohammadghasemipour Z; Department of Infectious Disease, School of Medicine, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Shirvaliloo M; Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, 5166614766, Iran.
  • Momeni MK; Department of Internal Medicine, School of Medicine, Clinical Immunology Research Center, Ali IbneAbitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Metanat M; Department of Infectious Disease, School of Medicine, Infectious Diseases and Tropical Medicine Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Bu Ali Hospital, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Gorgani F; Department of Infectious Disease, School of Medicine, Infectious Diseases and Tropical Medicine Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Bu Ali Hospital, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Abedipour F; Department of Infectious Disease, School of Medicine, Infectious Diseases and Tropical Medicine Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Bu Ali Hospital, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Mohammadi M; Department of Biostatistics and Epidemiology, School of Health, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Sartipi M; Department of Biostatistics and Epidemiology, School of Health, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Khorashad ARS; Department of Parasitology and Mycology, School of Medicine, Infectious Diseases and Tropical Medicine Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Shahraki O; Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Ataee M; Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran.
  • Sheervalilou R; Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran. sheervalilour@tbzmed.ac.ir.
  • Sargazi S; Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, 9816743463, Iran. sheervalilour@tbzmed.ac.ir.
Inflammopharmacology ; 30(5): 1645-1657, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35834150
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Ciclo-Oxigenase 2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Inflammopharmacology Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Ciclo-Oxigenase 2 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Inflammopharmacology Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã